Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Metastatic squamous cell carcinoma of the cervix: complete response under maintenance strategy with bevacizumab
F. Lai-Tiong1, *
1 Oncology Unit Gard Cancer Institute, Nîmes, France
Eur. J. Gynaecol. Oncol. 2018, 39(5), 828–829; https://doi.org/10.12892/ejgo4002.2018
Published: 10 October 2018
Cervical carcinoma is a common cancer. Metastatic disease will develop in 15% to 61% percent women, usually within the first two years of completing treatment. We present a case of a 56-year-old patient with a Stage IIIB carcinoma of the cervix, treated with chemoradiation, brachytherapy and surgery. Nine months after completion of primary treatment, she presented with latero-aortic metastatic adenomegalies. She received six courses of chemotherapy carboplatin+paclitaxel+bevacizumab, followed by maintenance by bevacizumab. After ten months of bevacizumab and three years after the diagnosis, the patient is alive, without further evidence of disease.